☆ 4.4 Article

In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells

CELL BIOCHEMISTRY AND FUNCTION (2022)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction

Bikash Chandra Jena et al.

Summary: The tumor microenvironment (TME) is a complex network of cellular organization supporting tumor growth through intercellular communication, with a pivotal role in the development of anti-cancer drug resistance. Exosomes have emerged as key players in mediating bidirectional interplay between tumor and TME, promoting drug resistance and challenging therapeutic strategies.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

The characterization of exosomes from fibrosarcoma cell and the useful usage of Dynamic Light Scattering (DLS) for their evaluation

Tae Seong Lyu et al.

Summary: The study analyzed exosomes from a fibrosarcoma cell line WEHI-164 and a breast cancer cell line MDA-MD-231, revealing different protein components in exosomes from WEHI-164 and demonstrating DLS as a useful tool for assessing homogeneity and size of exosomes.

PLOS ONE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Potential roles and prognostic significance of exosomes in cancer drug resistance

Mostafa Mostafazadeh et al.

Summary: Exosomes play potential roles in tumor initiation, progression, and chemoresistance by mediating cell-to-cell communication and affecting drug resistance. Studies have shown that the content of exosomes released from tumor cells may be associated with the clinical outcomes of cancer patients.

CELL AND BIOSCIENCE (2021)

Add to Collection

Review Oncology

Current Perspectives on the Role of Nrf2 in 5-Fluorouracil Resistance in Col-orectal Cancer

Jiayi Gong et al.

Summary: This study discussed the role and mechanisms of Nrf2 in 5-FU resistance and explored potential medicines or compounds that can reverse Nrf2-mediated resistance. Previous research indicated that overactivation of Nrf2 contributes to 5-FU resistance by regulating cytoprotective genes, and some medications and compounds have shown promise in overcoming Nrf2-mediated resistance.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Cell Biology

Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis

Hong-Wei Zhang et al.

Summary: In colon cancer, high expression of miR-24-3p and low expression of HEPH and CDX2 were observed in tissues and cells. CDX2, targeted by miR-24-3p, could up-regulate HEPH. Inhibition of CAF-derived exosomal miR-24-3p decreased cell viability and colony formation, and increased apoptosis, indicating a role in promoting chemotherapy resistance in colon cancer.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer

Tao Ning et al.

Summary: Our study demonstrates that miR-208b may serve as a non-invasive marker for predicting the sensitivity of CRC patients to FOLFOX chemotherapy. Colon cancer cell-secreted miR-208b promotes Treg expansion by targeting PDCD4, leading to tumor growth and oxaliplatin resistance.

MOLECULAR THERAPY (2021)

Add to Collection

Article Cell Biology

A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer

Xuan Deng et al.

Summary: The study identified PiHL as a promoter of chemoresistance in CRC, with its role in activating the EZH2/HMGA2/PI3K/Akt signaling axis to confer oxaliplatin resistance. Targeting PiHL restored sensitivity to oxaliplatin in resistant CRC cells, indicating a potential novel strategy for overcoming drug resistance.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Integrative & Complementary Medicine

Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells

Sanya Haiaty et al.

Summary: The study showed that TQ could inhibit the proliferation and vasculogenic capacity of human breast CSCs, reduce the metastasis of tumor cells, and suppress MendT phenomenon. TQ also had the potential to decrease the number of CD24(-) CSCs and Rhodamine 123 efflux capacity, indicating its anti-tumor effects.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Exosomal Nrf2: From anti-oxidant and anti-inflammation response to wound healing and tissue regeneration in aged-related diseases

Houman Kahroba et al.

BIOCHIMIE (2020)

Add to Collection

Article Surgery

Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways

Yoon Jin Lee et al.

ANNALS OF SURGICAL TREATMENT AND RESEARCH (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Autophagy-Independent Functions of the Autophagy Machinery

Lorenzo Galluzzi et al.

CELL (2019)

Add to Collection

Article Oncology

Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells

Qian Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Colon cancer cells secrete exosomes to promote self-proliferation by shortening mitosis duration and activation of STAT3 in a hypoxic environment

Ruixue Ren et al.

CELL AND BIOSCIENCE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

microRNA-193a-5p inhibits migration of human HT-29 colon cancer cells via suppression of metastasis pathway

Naghmeh Shirafkan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance

Y-B Hu et al.

ONCOGENE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer

Houman Kahroba et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Add to Collection

Article Medicine, Research & Experimental

Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer

Mohammad Reza Sadeghi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Article Medicine, Research & Experimental

Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer

Farhad Jeddi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Article Medicine, Research & Experimental

The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells

Abbas Pirpour Tazehkand et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model

Xue Li et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Add to Collection

Article Oncology

UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer

Kuan Ning et al.

JOURNAL OF SURGICAL ONCOLOGY (2017)

Add to Collection

Review Oncology

The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance

Mohammad Reza Sadeghi et al.

TUMOR BIOLOGY (2017)

Add to Collection

Review Oncology

Tumor-derived exosomes in colorectal cancer progression and their clinical applications

Jianbiao Zhou et al.

ONCOTARGET (2017)

Add to Collection

Review Genetics & Heredity

Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance

Farhad Jeddi et al.

DNA REPAIR (2017)

Add to Collection

Review Gastroenterology & Hepatology

Mechanisms of drug resistance in colon cancer and its therapeutic strategies

Tao Hu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection

Article Oncology

Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer

Taku Kato et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)

Add to Collection

Article Oncology

In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies

Martina McDermott et al.

FRONTIERS IN ONCOLOGY (2014)

Add to Collection

Article Oncology

High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer

Tao Jiang et al.

CANCER RESEARCH (2010)

Add to Collection

Article Oncology

Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer

Shinsuke Homma et al.

CLINICAL CANCER RESEARCH (2009)

Add to Collection

Article Oncology

Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells

Hanane Akhdar et al.

EUROPEAN JOURNAL OF CANCER (2009)

Add to Collection

Article Pharmacology & Pharmacy

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy

MA Summers et al.

ANNALS OF PHARMACOTHERAPY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.